RT Journal Article
T1 Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects
A1 Manzano García, Miguel
A1 Vallet Regí, María Dulce Nombre
AB Mesoporous Silica Nanoparticles (MSNs) represent a versatile platform in biomedicine thanks to their unique structural properties and functional versatility. These nanoparticles are at the forefront, offering exceptional biocompatibility, tunable pore sizes, and surface functionalization to enhance drug loading and controlled release. On top of that, stimuli-responsive MSNs can be designed to respond to specific triggers such as pH, temperature, or light. These smart MSNs further optimize drug delivery by ensuring targeted release and minimizing side effects. Beyond drug delivery applications, mesoporous materials are increasingly utilized in tissue regeneration, providing scaffolds that promote cell growth and integration. In bone-related pathologies, these materials exhibit significant potential, enhancing mineralization and facilitating the repair of osseous defects. Future perspectives focus on advancing the multifunctionality of MSNs, integrating imaging, therapeutic, and diagnostic capabilities into single platforms. The remarkable adaptability of MSNs ensures their continued evolution, paving the way for innovative solutions to complex biomedical challenges.
PB Wiley
YR 2025
FD 2025-07-05
LK https://hdl.handle.net/20.500.14352/123637
UL https://hdl.handle.net/20.500.14352/123637
LA eng
NO Manzano M, Vallet‐Regí M. Mesoporous silica nanoparticles in biomedicine: advances and prospects. Advanced Materials [Internet]. 25 de agosto de 2025 [citado 3 de septiembre de 2025];e12433. Disponible en: https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202512433
NO Comunidad de Madrid
NO European Commission
DS Docta Complutense
RD 18 mar 2026